Free CME's

Exploring Novel Clinical Trial Designs for Gene-Based Therapies - A Workshop is organized by The Health and Medicine Division of the National Academies of Sciences, Engineering and Medicine (HMD-NASEM) and will be held on Nov 13, 2019 at National Academy of Sciences, Washington, Dist of Col, United States of America.  Description: Designing clinical trials to test the safety and efficacy of regenerative medicine therapies, such as gene- and gene-editing- based therapies, can be complex for several reasons including challenges with determining an optimal dosage, delivering the product effectively, and successfully recruiting patients, to name a few. Patients and clinicians may also face difficult decisions about enrollment in a gene therapy or trial in certain instances where the trial is considered to offer a “single chance,” possibly making the patients ineligible for future trials. To further explore the design complexities and ethical issues associated with clinical trials for these types of therapies, the Forum on Regenerative Medicine will hold a one-day workshop in Washington, DC on November 13, 2019. Speakers at the workshop may be asked to discuss patient recruitment and selection for gene-based clinical trials, assessing the safety of new therapies, dose escalation, and ethical issues such as informed consent and the role of clinicians in recommending trials as options to their patients. The concept of repeat dosing and sensitization treatments may also be explored. A broad array of stakeholders may take part in the workshop, including academic and industry researchers, regulatory officials, clinicians, bioethicists, and individuals/patients and patient advocacy groups. Additional details will be posted as soon as information is available.

Improving Outcomes on the Frontlines of Atopic Dermatitis Care is organized by Prime Education, LLC and will be held on Nov 13, 2019 at Dutch's Daughter Restaurant, Frederick, Maryland, United States of America. Accreditation: This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change. Physician Credit Designation Statement: PRIME® designates this Live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. Physician Assistant Accreditation Statement: PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Nurse Practitioner Accreditation Statement: Nurse Practitioner LogoPRIME® is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.5 contact hours of continuing education (which includes 0.12 hours of pharmacology). Nurse Accreditation Statement: PRIME® designates this activity for 1.5 contact hours. Learning Objectives: • Apply validated methods for atopic dermatitis (AD) diagnosis and disease severity assessment in adult and pediatric patients • Evaluate current efficacy and safety evidence on new therapies for patients with moderate to severe AD • Incorporate methods to support patients with AD in accessing and adhering to needed therapies. Additional details will be posted as soon as information is available.

Endovascular Advances: A Hands-On Preceptorship Program is organized by Academy for Continued Healthcare Learning (ACHL) and will be held from Nov 14 - 15, 2019 at New Mexico Heart Institute at Lovelace Medical Center, Albuquerque, New Mexico, United States of America. The target audience for this medical event is vascular surgeons, interventional cardiologists, and interventional radiologists looking to expand their hands-on experience in the treatment of peripheral arterial disease. This CME Conference has been approved for a maximum of 16.5 AMA PRA Category 1 Credits™. Description: This CME activity is designed to provide physicians with hands-on training in all aspects of managing complex lower extremity disease, including: SFA interventions, chronic limb ischemia, and chronic total occlusions. Approved attendees will be trained for a two-day program under the direct supervision of the program faculty at the program site. Objectives: • Analyze risk assessment and diagnostic methods in PAD • Explore alternative access options and techniques (i.e. pedal access, popliteal access) • Discuss treatment algorithms and best practices  • Formulate strategies for complication management  • Evaluate various SFA and CTO tools and treatment strategies, including vessel preparation with atherectomy and new technologies in the era of drug elution.

Diagnosing and Treating Irritable Bowel Syndrome (IBS-D) for Primary Care Clinicians is organized by University of Louisville (UL) School of Medicine and will be held on Nov 14, 2019 at Houston, Texas, United States of America. Target Audience: Internists, Family Physicians, Gastroenterologists, Physician Assistants, Nurse Practitioners and RN’s. Designation Statement: The University of Louisville School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses - This program has been approved by the Kentucky Board of Nursing for 1.2 continuing education credits through University of Louisville Hospital, provider number 4-0068-7-20-1125. Description: This activity will provide physicians and mid-level providers a good foundation of the symptoms, diagnostic approaches and treatment therapies for patients with irritable bowel syndrome with diarrhea (IBS-D) and IBS-C (constipation). Additional details will be posted as soon as they are available.

Cardiac S.T.A.B.L.E. Course is organized by University Health System (UHS) and will be held on Nov 14, 2019 at University Hospital - University Health System, San Antonio, Texas, United States of America. This CEU Conference has been approved for a maximum of 4 CEUs. Course Description: University Hospital Neonatal Intensive Care Unit offers S.T.A.B.L.E. Learner/Provider courses. This neonatal education program focuses on post-resuscitation/pre-transport stabilization care of sick infants. The class goal is to decrease infant morbidity and mortality, improve neonatal outcomes and the quality of life for infants and their families! Additional details will be posted as soon as they are available.

Educating Health Professionals to Address the Social Determinants of Mental Health: A Workshop is organized by The Health and Medicine Division of the National Academies of Sciences, Engineering and Medicine (HMD-NASEM) and will be held from Nov 14 - 15, 2019 at Keck Center of the National Academies, Washington, Dist of Col, United States of America. Description: A planning committee will plan and conduct a 1.5-day public workshop to explore how health professions education and practice organizations and programs, are currently addressing social determinants that contribute to mental health disparities across the lifespan. The workshop will also set the stage for discussions on how disparities can affect the mental health and well-being of patients, families, communities, and care providers across the learning continuum. The planning committee will develop a workshop agenda, select and invite speakers and discussants, and moderate the discussions. Following the workshop, a proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines. Workshop Objective: To understand the mental and physical health impacts of being exposed to the social determinants from a Macro and Mezzo level so the knowledge can be applied in a Micro level. Topics: Education, Global Health, Health Care Workforce Additional details will be posted as soon as information is available.

Washington State Medical Oncology Society (WSMOS) Fall 2019 Oncology Conference is organized by Washington State Medical Oncology Society (WSMOS) and will be held on Nov 15, 2019 at Cedarbrook Lodge, Seattle, Washington, United States of America. Practicing Physicians/NPs/PAs and their supporting staff are welcome to attend at no cost. Additional details will be posted as soon as they are available.

Real-World Applications of Clinical Trial Data and Changing Guidelines in IBD is organized by Prime Education, LLC and will be held on Nov 19, 2019. Intended Audience: Physicians, Nurse Practitioners, Physician Assistants, Nurses, and Pharmacists Accreditation: This activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change. Physician Credit Designation Statement: PRIME® designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. ACCME MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Physician Assistant Accreditation Statement: PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation. Nurse Practitioner Accreditation Statement: Nurse Practitioner LogoPRIME® is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour of continuing education (which includes 0 hours of pharmacology). Pharmacist Accreditation Statement: This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-19-078-L01-P. Pharmacy CE credits can be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net). Nurse Accreditation Statement: PRIME® designates this activity for 1.0 contact hour. Course Description: This webinar brings experts from across the aisle to discuss how the latest evidence-including hot-off-the-press data from the ACG and UEG meetings-and newly updated guidelines are shaping current approaches to the treatment and management of inflammatory bowel disease (IBD). Learning Objectives: • Align managed care and specialty pharmacy strategies with evidence-based IBD guidelines and treat-to-target approaches for achieving evolving treatment goals, including mucosal healing and steroid-free remission • Apply recent research on the comparative effectiveness of biologics to therapy selection for patients with IBD • Develop managed care and specialty pharmacy frameworks that account for evolving therapeutic mechanisms and routes of administration in IBD.

Cosmetic Show & Upcoming Beauty Trade Show 2019 is organized by BtoB Events Limited and will be held from Nov 20 - 22, 2019 at Landmark Centre, Lagos, Nigeria. Description: Cosmetic Show & Beauty Trade Show 2019 is a platform for companies to do business, with cosmetic makeup and cosmetic products distributors, suppliers & importers from West Africa. If you get more info about the show then call us or visit us! Beauty West Africa 2019 will host buyers and decision makers from both sectors, including: • Distributors, importers, and suppliers • Retail stores • Salon owners • Spa Owners • Makeup artists • Beauticians • Aesthetic clinics • Business owners • Product users More… Pre-Register for FREE! Additional details will be posted as soon as they are available.

Parents with PTSD: How Addiction Can Re-traumatize Families is organized by National Association for Alcoholism and Drug Abuse Counselors (NAADAC) and will be held on Nov 20, 2019. Earn Continuing Education Hours (CEs): NAADAC members receive a CE certificate for 1 CE for free. Non-members of NAADAC can receive 1 CE for $15 (make payment here). A CE certificate will be emailed to you within 21 days of submission and receiving payment, if applicable. Target Audience: Addiction professionals, employee assistance professionals, social workers, mental health counselors, professional counselors, psychologists, and other helping professionals that are interested in learning about addiction-related matters. Description: It is well documented that addiction can have significant collateral impacts on parents, extended family, partners and friends. But what happens when these care-givers and supports also have their own Adverse Childhood Experiences (ACES) history? Living with, loving, and supporting a person with addiction can become personal: triggering parents, partners, and families to relive their own trauma history. This presentation will discuss how ACES can impact the family system, and will address specific support/treatment strategies using Acceptance and Commitment Therapy (ACT) and Mindfulness. Also addressed will be the CDC-Kaiser Permanente Adverse Childhood Experiences Study, a body of groundbreaking research that looked at how childhood trauma affects long-term health. Learning Objectives: • Gain an understanding of overall ACES research and principles of trauma therapy from Acceptance and Commitment Therapy (ACT) and Mindfulness perspective. • Understand how the experience of addiction can be re-traumatizing for families, partners, and other close supports. • Encourage the use of practical trauma-informed containment and treatment strategies that can be used with parents, families, partners, and other caregivers.